All‐cause mortality · people undergoing laparoscopic cholecystectomy.
1 finding from 1 review
All‐cause mortality · adults with oesophageal varices
Band ligation probably leads to lower mortality compared with no intervention (moderate certainty).
1 finding from 1 review
All‐cause mortality · people with paracetamol (acetaminophen) overdose
It is very uncertain whether methionine and supportive treatment changes mortality compared with supportive treatment (very low certainty).
1 finding from 1 review
All‐cause mortality · people with paracetamol (acetaminophen) overdose
1 finding from 1 review
All‐cause mortality · people with fulminant hepatic failure secondary to paracetamol (acetaminophen) overdose
Intravenous acetylcysteine may leads to lower mortality compared with placebo (low certainty).
1 finding from 1 review
All‐cause mortality · people with paracetamol (acetaminophen) overdose
1 finding from 1 review
All‐cause mortality · people with paracetamol (acetaminophen) overdose
1 finding from 1 review
All‐cause mortality · people with paracetamol (acetaminophen) overdose
It is very uncertain whether charcoal haemoperfusion changes mortality compared with no intervention (very low certainty).
1 finding from 1 review
All‐cause mortality · people with paracetamol (acetaminophen) overdose
It is very uncertain whether cysteamine changes mortality compared with no intervention (very low certainty).
1 finding from 1 review
All‐cause mortality · people with paracetamol (acetaminophen) overdose
It is very uncertain whether cysteamine changes mortality compared with dimercaprol (very low certainty).
1 finding from 1 review
All‐cause mortality · people with paracetamol (acetaminophen) overdose
1 finding from 1 review
All‐cause mortality · people with paracetamol (acetaminophen) overdose
1 finding from 1 review
All‐cause mortality · adults with cirrhosis and gastroesophageal varices
Carvedilol showed no clear difference in mortality compared with traditional, non‐selective beta‐blockers (low certainty).
1 finding from 1 review
All‐cause mortality
It is very uncertain whether L‐ornithine L aspartate changes mortality compared with placebo or no intervention (very low certainty).
1 finding from 1 review
All‐cause mortality · people with cirrhosis who had minimal or overt hepatic encephalopathy or who were at risk for developing hepatic encephalopathy;…
It is very uncertain whether L‐ornithine L‐aspartate changes mortality compared with probiotic (very low certainty).
1 finding from 1 review
All‐cause mortality · people with cirrhosis who had minimal or overt hepatic encephalopathy or who were at risk for developing hepatic encephalopathy;…
It is very uncertain whether L‐ornithine L‐aspartate changes mortality compared with rifaximin (very low certainty).
1 finding from 1 review
All‐cause mortality · people with cirrhosis who had minimal or overt hepatic encephalopathy or who were at risk for developing hepatic encephalopathy;…
It is very uncertain whether L‐ornithine L‐aspartate changes mortality compared with lactulose (very low certainty).
1 finding from 1 review
All‐cause mortality · people with hepatorenal syndrome
Terlipressin may leads to lower mortality compared with placebo or no intervention (low certainty).
1 finding from 1 review
All‐cause mortality · people with primary sclerosing cholangitis
It is very uncertain whether ursodeoxycholic acid changes mortality compared with placebo (very low certainty).
1 finding from 1 review
All‐cause mortality · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review